4//SEC Filing
Bukofzer Stan 4
Accession 0001005201-20-000005
CIK 0001005201other
Filed
Feb 5, 7:00 PM ET
Accepted
Feb 6, 5:48 PM ET
Size
9.2 KB
Accession
0001005201-20-000005
Insider Transaction Report
Form 4
Bukofzer Stan
Chief Medical Officer & SVP***
Transactions
- Award
Restricted Stock Units
2020-02-04+326,577→ 326,577 totalExp: 2023-02-04→ Common Stock (326,577 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the registrant's common stock.
- [F2]One-third of these restricted stock units are scheduled to vest on each of February 4, 2021, 2022 and 2023, assuming continued employment through the applicable vesting date.
- [F3]The derivative securities were granted to the reporting person, and were not sold to the reporting person. As such, the reporting person did not pay any consideration for the derivative securities.
Issuer
Assertio Therapeutics, Inc
CIK 0001005201
Entity typeother
Related Parties
1- filerCIK 0001663041
Filing Metadata
- Form type
- 4
- Filed
- Feb 5, 7:00 PM ET
- Accepted
- Feb 6, 5:48 PM ET
- Size
- 9.2 KB